In this study, 132 pathways were enriched (P < 0.05), suggesting that the putative targets were highly connected with the regulation of prostate cancer, pancreatic cancer, estrogen signaling pathway, vascular endothelial growth factor (VEGF) signaling pathway, small cell lung cancer, and mitophagy. This evidence concerns the gene VEGFA and pancreatic neoplasm.